Empagliflozin in heart failure patients with preserved ejection fraction and diabetes mellitus type 2. (Results of a pilot prospective randomized trial)
A. Ovchinnikov, A. Borisov, K. Zherebchikova, O. Ryabtseva, A. Gvozdeva, V. Masenko, F. Ageev
{"title":"Empagliflozin in heart failure patients with preserved ejection fraction and diabetes mellitus type 2. (Results of a pilot prospective randomized trial)","authors":"A. Ovchinnikov, A. Borisov, K. Zherebchikova, O. Ryabtseva, A. Gvozdeva, V. Masenko, F. Ageev","doi":"10.17116/cardiobulletin20211603160","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":305396,"journal":{"name":"Kardiologicheskii vestnik","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kardiologicheskii vestnik","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/cardiobulletin20211603160","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}